Humana Inc. (NYSE:HUM) Shares Sold by Aurora Investment Counsel

Aurora Investment Counsel trimmed its stake in Humana Inc. (NYSE:HUM) by 2.8% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 1,719 shares of the insurance provider’s stock after selling 49 shares during the period. Aurora Investment Counsel’s holdings in Humana were worth $642,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in HUM. Mendota Financial Group LLC raised its position in Humana by 9.2% in the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock valued at $119,000 after purchasing an additional 27 shares during the period. Capital Advisors Ltd. LLC grew its stake in shares of Humana by 17.0% in the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after buying an additional 31 shares in the last quarter. EP Wealth Advisors LLC raised its holdings in shares of Humana by 1.6% in the 4th quarter. EP Wealth Advisors LLC now owns 2,294 shares of the insurance provider’s stock valued at $1,050,000 after buying an additional 37 shares during the period. CarsonAllaria Wealth Management Ltd. lifted its stake in Humana by 111.4% during the 2nd quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares in the last quarter. Finally, Harbour Investments Inc. boosted its holdings in Humana by 10.5% during the 2nd quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock valued at $161,000 after acquiring an additional 41 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on HUM shares. Deutsche Bank Aktiengesellschaft lifted their target price on Humana from $341.00 to $349.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Piper Sandler started coverage on shares of Humana in a report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price objective for the company. JPMorgan Chase & Co. increased their target price on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a report on Wednesday, August 21st. Truist Financial raised their price target on shares of Humana from $355.00 to $400.00 and gave the company a “hold” rating in a research report on Monday, July 15th. Finally, Royal Bank of Canada upped their price objective on Humana from $385.00 to $400.00 and gave the stock an “outperform” rating in a research report on Thursday, September 5th. Thirteen investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $398.70.

Humana Price Performance

Shares of NYSE HUM opened at $316.60 on Tuesday. The stock’s 50-day simple moving average is $348.57 and its 200-day simple moving average is $344.23. The firm has a market capitalization of $38.15 billion, a PE ratio of 19.71, a price-to-earnings-growth ratio of 2.44 and a beta of 0.50. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $530.54. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 EPS for the quarter, beating the consensus estimate of $5.89 by $1.07. The company had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. Humana had a net margin of 1.53% and a return on equity of 16.12%. The firm’s revenue was up 10.4% on a year-over-year basis. During the same period in the prior year, the firm posted $8.94 earnings per share. As a group, equities research analysts forecast that Humana Inc. will post 16.01 EPS for the current fiscal year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be paid a dividend of $0.885 per share. The ex-dividend date is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.12%. Humana’s dividend payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.